[Effectiveness of mesoglycan topical treatment of leg ulcers in subjects with chronic venous insufficiency]
- PMID: 10630070
[Effectiveness of mesoglycan topical treatment of leg ulcers in subjects with chronic venous insufficiency]
Abstract
Background: Aim of the present comparative clinical study was to demonstrate the efficacy of the topical application of mesoglycan, a profibrinolytic agent, for healing of leg ulcers in patients with chronic venous insufficiency.
Methods: Forty patients, observed in our outpatients department, with venous leg ulcers have been randomized in two groups of twenty subjects, each treated with topical application of mesoglycan (1 or 2 vials/day) or vegetal stimulins and followed for two months, with controls after 15, 30 and 60 days.
Results: At the end of the observation period, ulcer healing rate was 95% in the mesoglycan group, while a lower healing rate was obtained in the stimulins group (80%).
Conclusions: The present study confirms previous clinical experiences with mesoglycan and suggests its application in the topical treatment of venous ulcers.
Similar articles
-
A placebo-controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers.Eur J Vasc Endovasc Surg. 2001 Oct;22(4):365-72. doi: 10.1053/ejvs.2001.1478. Eur J Vasc Endovasc Surg. 2001. PMID: 11563899 Clinical Trial.
-
Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.Minerva Cardioangiol. 2007 Dec;55(6):741-53. Minerva Cardioangiol. 2007. PMID: 18091643
-
[Effectiveness of mesoglycan therapy in patients with ischemia of the lower limbs. Preliminary results of a new therapeutic protocol].Minerva Cardioangiol. 1997 Jul-Aug;45(7-8):383-92. Minerva Cardioangiol. 1997. PMID: 9463174 Italian.
-
Factor XIII in ulcerative leg disease: background and preliminary clinical results.Semin Thromb Hemost. 1996;22(5):445-50. doi: 10.1055/s-2007-999044. Semin Thromb Hemost. 1996. PMID: 8989829 Review.
-
Sulodexide in the treatment of chronic venous disease.Am J Cardiovasc Drugs. 2012 Apr 1;12(2):73-81. doi: 10.2165/11599360-000000000-00000. Am J Cardiovasc Drugs. 2012. PMID: 22329592 Review.
Cited by
-
Clinical evidence and rationale of mesoglycan to treat chronic venous disease and hemorrhoidal disease: a narrative review.Updates Surg. 2024 Apr;76(2):423-434. doi: 10.1007/s13304-024-01776-9. Epub 2024 Feb 14. Updates Surg. 2024. PMID: 38356039 Free PMC article. Review.
-
Venous leg ulcers.BMJ Clin Evid. 2011 Dec 21;2011:1902. BMJ Clin Evid. 2011. PMID: 22189344 Free PMC article.
-
Venous leg ulcers.BMJ Clin Evid. 2008 Sep 15;2008:1902. BMJ Clin Evid. 2008. PMID: 19445798 Free PMC article.
-
Dressings and topical agents for treating venous leg ulcers.Cochrane Database Syst Rev. 2018 Jun 15;6(6):CD012583. doi: 10.1002/14651858.CD012583.pub2. Cochrane Database Syst Rev. 2018. PMID: 29906322 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical